Investment Advisors
Each UCeed fund is backed by an Investment Advisory Group who review and advise on Fund investments. These advisors are hand-selected, experienced professionals with deep sector experience, proven leadership, and knowledge and experience in early-stage investing. Advisors provide mentorship, deep-rooted community connections, and critical support through the investment decision-making process and third-party validation.
Innovate Calgary is responsible for the management and operation of the UCeed Fund. With support from the Innovate Calgary management team, Investment Advisory Groups meet on a set schedule — as often as quarterly — to make recommendations and investment decisions. Discussions include:
Investments
What investments are to be made using monies from the fund and rationale for such recommendations.
Considerations
Considerations regarding financial terms, risks, concerns, or other factors.
Key milestones
Key milestone activities for each investee company.
Agreements
The general terms and conditions of the template funding agreements.
Investment Advisory Group - Haskayne Student Fund

Vincent Chahley

Heather Marshall

Ari Pandes

Brent Matterson

Myles Sheddon

Alex Morley
Investment Advisory Group - Child Health and Wellness Fund

Alice Reimer

Mike Begin

Chen Fong

Derrick Hunter

James Lochrie

Zain Kassam

Meg Bregazzi
Investment Advisory Group - Health Fund

Mike Begin

Meg Bregazzi

Chen Fong

Derrick Hunter

Zain Kassam

James Lochrie

Alice Reimer
Investment Advisory Group - Social Impact Fund
Investment Advisory Group - UCeed Energy Fund

Don Archibald

Matthew Brister

Colin Bergman

Erin Madro

Lorraine Mitchelmore

Martin Molyneaux
Clinical Advisory Board
The marketplace success of novel therapeutics, diagnostics, medical devices, and other healthcare products often depends on nuanced factors that require frontline clinician feedback to assess. The Clinical Advisory Board (CAB) is a group of physician volunteers who leverage their networks to connect UCeed Health staff to frontline clinicians who provide feedback on the clinical utility and feasibility of healthcare products and services in development by prospective investee companies. We are deeply grateful for their valuable assistance.